SLE flares are characterized by the development and progressive accrual of autoantibodies, exaggerated pro-inflammatory type I interferon (IFN) production, and impaired apoptotic clearance, which drives cumulative damage to tissues and organs, such as the skin, joints, and kidneys. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.